Your browser doesn't support javascript.
loading
Hydrolysis-Kinetic Study of AEBSF, a Protease Inhibitor Used during Cell-Culture Processing of the HIV-1 Broadly Neutralizing Antibody CAP256-VRC25.26.
Huang, Jesse L; Nagy, Attila; Ivleva, Vera B; Blackstock, Daniel; Arnold, Frank; Cai, Cindy X.
Afiliação
  • Huang JL; University of Maryland , College Park , Maryland , United States.
  • Nagy A; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health , Gaithersburg , Maryland , United States.
  • Ivleva VB; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health , Gaithersburg , Maryland , United States.
  • Blackstock D; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health , Gaithersburg , Maryland , United States.
  • Arnold F; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health , Gaithersburg , Maryland , United States.
  • Cai CX; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health , Gaithersburg , Maryland , United States.
Anal Chem ; 90(7): 4293-4296, 2018 04 03.
Article em En | MEDLINE | ID: mdl-29508618
ABSTRACT
One approach to mitigate product clipping during HIV mAb CAP256-VRC26.25 cell-culture development is the addition of the protease inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF) to the cell-culture media. AEBSF can undergo hydrolysis to form an inactive compound, 4-(2-aminoethyl) benzenesulfonic acid. Using mass-spectrometry detection, a kinetic profile of AEBSF hydrolysis was generated for conditions simulating those of cell culture at pH 7.0 and 37 °C. It was found that increasing the pH or the temperature could accelerate AEBSF hydrolysis. The kinetic-study results in this report provide an analytical characterization and guidance when optimizing an AEBSF-addition strategy for product-clipping control during cell-culture development and offer an alternative approach for AEBSF-related clearance studies post protein production.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Inibidores de Proteases / Benzenossulfonatos / Anticorpos Anti-HIV / HIV-1 / Meios de Cultura / Anticorpos Neutralizantes / Anticorpos Monoclonais Idioma: En Revista: Anal Chem Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Inibidores de Proteases / Benzenossulfonatos / Anticorpos Anti-HIV / HIV-1 / Meios de Cultura / Anticorpos Neutralizantes / Anticorpos Monoclonais Idioma: En Revista: Anal Chem Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos